Event-free survival (EFS) with neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer (NSCLC) from CheckMate 816
Titel:
Event-free survival (EFS) with neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer (NSCLC) from CheckMate 816
Auteur:
Spicer, Jonathan Wang, Changli Tanaka, Fumihiro Chen, Ke-Neng Ito, Hiroyuki Liberman, Moishe Chen, Qixun Girard, Nicolas Lu, Shun Provencio, Mariano Mitsudomi, Tetsuya Awad, Mark Felip, Enriqueta Swanson, Scott Forde, Patrick Cai, Junliang Mahmood, Javed Hu, Nan Tran, Phuong Broderick, Stephen